Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
Select bar for recommendation details.
Recommendations | 14-Nov-24 | |
---|---|---|
Buy | 1 | |
Outperform | 1 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in GBX
The 2 analysts offering 12 month price targets for Arecor Therapeutics PLC have a median target of 340.50, with a high estimate of 361.00 and a low estimate of 320.00. The median estimate represents a 345.10% increase from the last price of 76.50.
High | 371.9% | 361.00 |
Med | 345.1% | 340.50 |
Low | 318.3% | 320.00 |
Earnings history & estimates in GBX
Average growth rate | -3.01% |
More ▼
Revenue history & estimates in GBP
Average growth rate | +98.91% |
More ▼